Key Highlights

● FIGS closed at $17.74 on October 12, 2026, up 12.42%.

● Renewed takeover and private-equity speculation and upgrade chatter drove the theme.

● No specific bid, deal value or rating target has been confirmed.

● FIGS sells fashion-forward scrubs, mainly online, to healthcare professionals.

FIGS Inc. (NYSE:FIGS), the direct-to-consumer maker of medical scrubs and healthcare apparel, advanced in Monday's session to close at $17.74 on October 12, 2026, a gain of 12.42%. Unlike many of the day's movers, FIGS rose on an identifiable, company-specific theme: renewed speculation about takeover and private-equity interest in the business, alongside chatter about more constructive analyst sentiment.

A History of Drawing Suitors

FIGS is no stranger to acquisition interest. The company has previously been the subject of take-private approaches from private-equity suitors, and those overtures have at times been publicly reported and debated among shareholders. Against that history, fresh talk of buyout or private-equity interest tends to find a receptive audience, because investors already view the company as a plausible candidate for a change-of-control transaction. When such speculation intensifies, shares frequently trade up toward the level where a deal is perceived as possible, even before, or in the absence of, any confirmed offer. That dynamic appears to be the dominant force behind Monday's move.

Takeover and Upgrade Chatter, Without Deal Terms

The theme driving the stock is takeover and private-equity interest together with upgrade chatter, but no specific bid, deal value or formal acquisition agreement dated to the October 12 session has been confirmed. Likewise, reports of improved analyst sentiment are best described as chatter rather than as a confirmed rating action with a stated price target. FIGS gained 12.42% to close at $17.74.

A Mixed Market With a Supportive Rotation

The broader market offered a backdrop that was, if anything, mildly supportive for a consumer-facing name like FIGS on Monday. The major indexes were mixed, with the Dow Jones Industrial Average up about 0.34% to roughly 51,830, the S&P 500 off about 0.13% to near 7,801, and the Nasdaq Composite down about 0.46% to around 27,240. The day's dominant currents were a surge in crude oil, which lifted energy shares after deadly weekend strikes on Riyadh's international airport raised supply fears, and a retreat across chip and other AI-linked stocks on concerns about the durability of AI capital spending.

Underneath those headlines, investors rotated toward value, healthcare and other areas outside the crowded technology trade. A healthcare-apparel company straddling consumer and medical end-markets can benefit at the margin from that kind of rotation, but the outsized, double-digit gain in FIGS is far better explained by the stock-specific takeover and upgrade speculation than by any broad sector tide.

A Brand Built Online

For context, FIGS built its brand around comfortable, fashion-forward scrubs sold primarily online to healthcare professionals, a model that has made it a recognizable name and, periodically, a talking point for would-be acquirers interested in its brand and customer base. Episodes of renewed deal speculation have historically been accompanied by sharp share-price reactions, and Monday fit that pattern.

Speculation Priced Into a Familiar Target

FIGS rose 12.42% to close at $17.74 on October 12, 2026, on reported takeover and private-equity interest and accompanying upgrade chatter, a company-specific driver rather than a sector-sympathy move. No specific offer, deal value or rating target has been confirmed, so the move is best framed as speculation-driven appreciation in a name with a demonstrated history of drawing suitors.